Study your tumor’s genetic results in a review board
Part of Blood & lymphatic, Cancer clinical trials.
This study collects genetic testing results from people with cancer and shares them with a specialized tumor review team. It may help future care planning by improving how tumor genetics are interpreted.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have (or your doctors suspect you have) cancer (solid tumors or blood cancers)
- You are currently doing genetic testing on your tumor sample
- You can read and understand the written consent form
- You are willing to sign the consent form
- You are 18 years old or older
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study uses a team review of your tumor’s gene test results to help match you with treatments you may benefit from. It’s designed for people whose tumor has specific gene changes that suggest sensitivity to available medicines or may involve inherited (germline) risk.
This trial sets up a “molecular tumor board,” a team that reviews your tumor’s lab results and helps your doctor choose treatment options. It may help by making sense of tumor test findings so decisions are more personalized.
This study looks at your tumor’s genetic information to help doctors recommend treatment for cancers that have spread. It may help you get the most suitable therapy based on what’s found in your tumor.
This trial uses special lab tests to look for tumor “molecular fingerprints” in your tumor or blood sample. The goal is to help your care team choose more personalized treatment options based on those results.
This study tests whether analyzing the DNA of your tumor (from a tissue sample or blood draw) can help find the best treatment for your advanced cancer. Researchers will look for genetic changes that could make you eligible for targeted therapy or a clinical trial.
This study uses a simple blood test to look at the genetic makeup of your tumor. The results may help your doctors choose the best treatment for you. You will need to provide a tumor sample or have a biopsy.
Hear when a new Hematologic Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.